About the Company
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ESPR News
ESPR Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C). Its marketed ...
Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 25.6% to $0.2840 in pre-market trading after dipping over 8% on Friday. The company, last week, announced a 1-for-20 reverse stock split.
Esperion Therapeutics Inc. (ESPR) Stock: Navigating the Market Volatility
Warren Eric, the Chief Commercial Officer of Esperion Therapeutics Inc., sale 243 shares at $1.41 during a trade that took place back on Aug 18 ’23, which means that Warren Eric is holding 69,060 ...
Esperion Therapeutics, Inc. Rings the Nasdaq Stock Market Opening Bell
Market open and close ceremonies take place daily at the Nasdaq MarketSite Studio in Times Square and around the globe. Esperion (Nasdaq: ESPR), a pharmaceutical company who recently announced the ...
Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc. is a pharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers ...
Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Shares of Esperion Therapeutics, Inc. ESPR shares rose sharply during today’s pre-market trading after the company presented new data from CLEAR outcomes at ACC.24 highlighting value of NEXLETOL ...
Esperion Therapeutics, Inc. (ESPR)
and MUNICH, Germany, March 22, 2024 (GLOBE NEWSWIRE) -- Daiichi Sankyo Europe GmbH (hereafter, ‘Daiichi Sankyo’) and Esperion Therapeutics, Inc. jointly announced today, that the Committ In ...
Esperion Therapeutics Inc 0ET
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Esperion Therapeutics Inc ESPR
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Esperion Therapeutics Inc.
For most investors, the best investment strategy is to buy good stocks and hold them for the long run.
Loading the latest forecasts...